The role of blinatumomab in ALL
Novel agent filanesib combination therapy for R/R multiple myeloma
CAR T-cells for lymphoma: data from ASH 2017
Ibrutinib and FCR chemoimmunotherapy: improving complete remission in CLL patients?
The influence of ibrutinib on progression-free survival and complete survival